Skip to Main Content

Meet Our Professionals

George T. Brady III

Raleigh | 919.835.4489
Fax | 919.835.4534

George Brady focuses his practice on mergers and acquisitions, private equity and venture capital transactions, and general corporate matters. He advises regional, national, and international clients – including public companies, private equity groups, and middle-market private companies – in a wide range of complex business transactions and has particular experience working on transactions in the health care, life sciences, building products and services, manufacturing, food and beverage, and automotive industries.

He also has experience with the Hart-Scott-Rodino Antitrust Improvement Act, including determination of the applicability of the act, advising clients regarding the act, and the preparation and coordination of the required filing.

George regularly provides legal counsel in the following areas:

  • Acquisition structures and strategies
  • Company sale transactions
  • Capitalization transactions
  • Joint ventures and strategic alliances
  • Corporate governance
  • Leveraged buyouts
  • Preferred and common stock placements
  • Licensing, distribution, and general commercial contracts
  • General corporate counsel
  • Entity formation

Representative Experience

  • Since 2010, represented the U.S. subsidiary of a British public company in more than 85 transactions involving the acquisition of equipment rental businesses.
  • Provides ongoing representation of middle market private equity firms in connection with platform and add-on acquisitions and recapitalization transactions. 
  • Represented the seller of a family-owned e-commerce business to a private equity group in a transaction valued at $95 million, in which the family retained a minority investment in the new enterprise.
  • Represented the founders of a manufacturing business in connection with the recapitalization of the company and the minority investment by a private equity group.
  • Regularly represents corporate venture funds and angel investors in equity financing investments in startup and emerging life sciences and technology companies.
  • Regularly represents entrepreneurs and startup companies in connection with general corporate matters and equity financings. 
  • Represented Solstas Lab Partners, a portfolio company of Welsh Carson, in connection with seven acquisitions of clinical laboratory businesses with an aggregate transaction value in excess of $150 million.
  • Served as counsel to a NYSE-listed company in more than 30 transactions involving the acquisition of clinical laboratory businesses.
  • Served as counsel to a packaging manufacturer in connection with the sale of its business via an auction process in a transaction valued in excess of $200 million.
  • Served as counsel to a privately held company in connection with the sale of its precision machining business and real property to a private equity investor.
  • Represented “stalking horse” buyers in connection with acquisitions pursuant to Section 363 of the bankruptcy code.
  • Served as counsel to a NYSE-listed company in more than 50 transactions involving the purchase and sale of automobile dealerships.

Loading content

Loading content

Honors & Awards

  • The Best Lawyers in America in Corporate Law, 2018-2021
  • Americas M&A Atlas Award for USA Recapitalization Deal, 2018
  • Martindale-Hubbell BV® Distinguished™ in Mergers, Acquisitions and Divestitures; Corporate Law; Securities
  • North Carolina Super Lawyers Rising Star, 2009, 2011
  • Phi Beta Kappa